Literature DB >> 12064847

Improving physical functional status in patients with fibromyalgia: a brief cognitive behavioral intervention.

David A Williams1, Meredith A Cary, Kimberly H Groner, William Chaplin, Lara J Glazer, Alyssa M Rodriguez, Daniel J Clauw.   

Abstract

OBJECTIVE: Sustained improvement in physical functional status was the primary goal of a brief, 6 session cognitive behavioral therapy (CBT) protocol for fibromyalgia (FM).
METHODS: One hundred forty-five patients with FM were randomly assigned to either (1) standard medical care that included pharmacological management of symptoms and suggestions for aerobic fitness, or (2) the same standard medical treatment plus 6 sessions of CBT aimed at improving physical functioning. Outcome measures included the Medical Outcome Study Short Form-36 Physical Component Score and McGill ratings of pain. Outcomes were treated dichotomously using a preestablished criterion for clinically significant success based upon the reliability of change index from baseline to one year posttreatment.
RESULTS: Twenty-five percent of the patients receiving CBT were able to achieve clinically meaningful levels of longterm improvement in physical functioning, whereas only 12% of the patients receiving standard care achieved the same level of improvement. There were no lasting differences on pain ratings between groups.
CONCLUSION: Lasting improvements in physical functioning have been among the most difficult outcomes to obtain in studies of FM. These data suggest that the inclusion of CBT to a standard medical regimen for FM can favorably influence physical functioning in a subset of patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12064847

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  35 in total

1.  Sustained pain reduction through affective self-awareness in fibromyalgia: a randomized controlled trial.

Authors:  Michael C Hsu; Howard Schubiner; Mark A Lumley; John S Stracks; Daniel J Clauw; David A Williams
Journal:  J Gen Intern Med       Date:  2010-06-08       Impact factor: 5.128

Review 2.  Understanding fibromyalgia: lessons from the broader pain research community.

Authors:  David A Williams; Daniel J Clauw
Journal:  J Pain       Date:  2009-08       Impact factor: 5.820

3.  Understanding fibromyalgia and its related disorders.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

4.  Exploratory Investigation of a Brief Cognitive Behavioral Intervention and Transcranial Direct Current Stimulation on Odor Sensitivity.

Authors:  David C Houghton; Thomas W Uhde; Jeffrey J Borckardt; Bernadette M Cortese
Journal:  Psychosom Med       Date:  2019-05       Impact factor: 4.312

Review 5.  [Fibromyalgia--a challenge for interdisciplinary management].

Authors:  Gerhard Fürst
Journal:  Wien Med Wochenschr       Date:  2007-01

6.  [Psychotherapy in patients with fibromyalgia syndrome].

Authors:  K Thieme; W Häuser; A Batra; K Bernardy; E Felde; M Gesmann; A Illhardt; M Settan; R Wörz; V Köllner
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

7.  Psychosocial Factors Predict Pain and Physical Health After Lower Extremity Trauma.

Authors:  Kristin R Archer; Christine M Abraham; William T Obremskey
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

8.  Successful reach and adoption of a workplace health promotion RCT targeting a group of high-risk workers.

Authors:  Marie B Jørgensen; Charlotte D N Rasmussen; Dorte Ekner; Karen Søgaard
Journal:  BMC Med Res Methodol       Date:  2010-06-14       Impact factor: 4.615

Review 9.  Systematic review of psychological treatment in fibromyalgia.

Authors:  María José Lami; María Pilar Martínez; Ana Isabel Sánchez
Journal:  Curr Pain Headache Rep       Date:  2013-07

10.  Combining cognitive-behavioral therapy and milnacipran for fibromyalgia: a feasibility randomized-controlled trial.

Authors:  Dennis C Ang; Mark P Jensen; Jennifer L Steiner; Janna Hilligoss; Richard H Gracely; Chandan Saha
Journal:  Clin J Pain       Date:  2013-09       Impact factor: 3.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.